Novanta Inc. (NOVT) AI Stock Analysis

Novanta Inc. designs, manufactures, and distributes photonics, vision, and precision motion components and subsystems globally to original equipment manufacturers across medical and industrial sectors. Its Photonics segment delivers laser scanning, CO2 lasers, solid-state lasers, ultrafast lasers, and optical light engines for industrial processing, metrology, medical imaging, and DNA sequencing. The Vision segment provides medical-grade equipment including insufflators, pumps, visualization tools, and machine vision technologies. The Precision Motion segment supplies optical and inductive encoders, precision motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology, and air bearings for motion control applications.

Novanta increased revenue from $706.8M in FY2021 to $980.6M in FY2025, generating a 5-year revenue CAGR of 10.7%. However, top-line growth decelerated to 3.3% in FY2025 compared to 7.7% in FY2024 and 21.8% in FY2022. Net income decreased to $53.8M in FY2025 from $74.1M in FY2022, with net margin narrowing to 5.5% as gross margin declined to 41.6%. Over the trailing twelve months, revenue totaled $1.03B with an operating margin of 11.5% and a profit margin of 6.0%. In the quarter ended June 30, 2026, revenue increased 10.3% year-over-year while quarterly earnings rose 150.0%.

As of June 30, 2026, Novanta held $718.6M in cash and short-term investments against total debt of $282.8M, yielding net cash of $435.8M. Liquidity is supported by a current ratio of 4.57 and a debt-to-equity ratio of 0.17 on shareholders' equity of $1.62B. For FY2025, operating cash flow was $64.1M and free cash flow reached $48.4M. Capital expenditures amounted to $15.6M, while share buybacks totaled $39.3M.

Novanta trades at a trailing P/E of 81.5x and an EV/EBITDA of 27.7x, both above the median of its US-listed Technology peers at 28.1x and 16.6x, respectively. The company's price-to-sales multiple of 4.7x is also elevated versus the peer median of 2.8x, though its forward P/E of 8.4x sits below the peer median of 18.8x. Over the past year, the shares gained 20.8%, outpacing the S&P 500 return of 16.8%. Over a 5-year period, the stock fell 20.3% compared to an 83.0% increase for the S&P 500.

Consensus sentiment includes 2 Strong Buy and 1 Buy ratings from analysts. The mean price target is $194.50, reflecting a 51.0% premium over the last closing price of $128.79. For the fiscal year ending December 31, 2026, analysts estimate EPS of $3.69 on revenue of $1.13B. For the following fiscal year, 3 analysts project EPS of $4.37 and revenue of $1.31B. Novanta has beaten EPS estimates in each of the last 4 quarters, with its next earnings release scheduled for November 9, 2026.

This page is an AI-written research summary of Novanta Inc. (NOVT). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: NOVT income statement, NOVT balance sheet, NOVT key metrics, NOVT analyst forecast, NOVT chart. See the NOVT stock overview for the latest quote and news.